Literature DB >> 6704019

Selection of therapeutic agents for intraocular proliferative disease. Cell culture evaluation.

M S Blumenkranz, A Claflin, A S Hajek.   

Abstract

A variety of antimetabolites, steroids, and nonsteroidal anti-inflammatory agents were tested for their ability to inhibit rabbit dermal and conjunctival fibroblast proliferation in cell culture. Doxorubicin hydrochloride and fluorouracil produced notable inhibition in concentrations of less than 1 mg/L. Meclofenamate sodium and indomethacin produced notable inhibition at concentrations of 11 and 40 mg/L, respectively. Dexamethasone sodium phosphate and triamcinolone acetonide produced inhibition at 200 and 150 mg/L, respectively, but paradoxically increased proliferation almost two-fold at concentrations ranging from 1 to 30 mg/L under identical culture conditions. Methotrexate sodium demonstrated only limited effectiveness. This assay system may be a useful approach to drug selection in the treatment of a variety of ocular proliferative disorders. Fluorouracil may prove to be of significant value in the treatment of intraocular proliferative disorders.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6704019     DOI: 10.1001/archopht.1984.01040030470029

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  26 in total

Review 1.  New developments in sustained release drug delivery for the treatment of intraocular disease.

Authors:  G Velez; S M Whitcup
Journal:  Br J Ophthalmol       Date:  1999-11       Impact factor: 4.638

2.  Evaluation of radiation therapy for experimental proliferative vitreoretinopathy in rabbits.

Authors:  S Kuriyama; T Ohuchi; N Yoshimura; Y Honda; M Hiraoka; M Abe
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

3.  Intravitreal triamcinolone acetonide as treatment for extensive exudative retinal detachment.

Authors:  J B Jonas
Journal:  Br J Ophthalmol       Date:  2004-04       Impact factor: 4.638

4.  Intravitreal triamcinolone for treatment of chronic focal immunological corneal graft reaction.

Authors:  Jost B Jonas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-08-26       Impact factor: 3.117

5.  Collagen synthesis activity in the aqueous humour of eyes with glaucoma surgery: a pilot study.

Authors:  A Tuulonen; J Risteli; L Risteli; J Välimäki; P J Airaksinen
Journal:  Br J Ophthalmol       Date:  1996-01       Impact factor: 4.638

6.  The Efficacy of Drug Injection in the Treatment of Pathological Scar: A Network Meta-analysis.

Authors:  Pengfei Sun; Xiaosheng Lu; Huachang Zhang; Zhensheng Hu
Journal:  Aesthetic Plast Surg       Date:  2019-12-18       Impact factor: 2.326

Review 7.  Hormesis and medicine.

Authors:  Edward J Calabrese
Journal:  Br J Clin Pharmacol       Date:  2008-06-28       Impact factor: 4.335

8.  Does the presence of heparin and dexamethasone in the vitrectomy infusate reduce reproliferation in proliferative vitreoretinopathy?

Authors:  R G Williams; S Chang; M R Comaratta; G Simoni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

Review 9.  The clinical applications of fluorouracil in ophthalmic practice.

Authors:  Lekha M Abraham; Dinesh Selva; Robert Casson; Igal Leibovitch
Journal:  Drugs       Date:  2007       Impact factor: 9.546

10.  Effects of selected repeated intravitreal chemotherapeutic agents.

Authors:  J Vernot; G A Peyman; R Gailitis; R Fiscella; M Woodhouse; D Weinberg
Journal:  Int Ophthalmol       Date:  1985-11       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.